The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of artificial intelligence–derived histological biomarkers for first-line treatment selection in metastatic pancreatic ductal adenocarcinoma (mPDAC).
 
Viswesh Krishna
Employment - Valar Labs
Stock and Other Ownership Interests - Valar Labs
Patents, Royalties, Other Intellectual Property - eyecare data processing
 
Ekin Tiu
Employment - Valar Labs
Travel, Accommodations, Expenses - Valar Labs
 
Vrishab Krishna
Employment - Valar Labs; Valar Labs (I)
Stock and Other Ownership Interests - Valar Labs; Valar Labs (I)
Patents, Royalties, Other Intellectual Property - eyesore data processing
 
Damir Vrabac
Employment - Valar Labs
Stock and Other Ownership Interests - Valar Labs
 
Kunal Shah
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Waleed Abuzeid
Employment - Valar Labs
Stock and Other Ownership Interests - Valar Labs
Consulting or Advisory Role - Acclarent/Johnson and Johnson
Patents, Royalties, Other Intellectual Property - automated video editing - U of Washington
 
Katelyn Smith
No Relationships to Disclose
 
John Davelaar
No Relationships to Disclose
 
Christopher Nuesca
No Relationships to Disclose
 
Brent K Larson
No Relationships to Disclose
 
Christos Fountzilas
Research Funding - Aravive (Inst); Astellas Pharma (Inst); Bellicum Pharmaceuticals (Inst); Bristol-Myers Squibb/Ono Pharmaceutical (Inst); Corcept Therapeutics (Inst); CrystalGenomics (Inst); Dragonfly Therapeutics (Inst); ERYTECH Pharma (Inst); Incyte (Inst); Ipsen (Inst); Kadmon (Inst); Kinex (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Rafael Pharmaceuticals (Inst); Seagen (Inst); Syndax (Inst); Taiho Oncology (Inst); TransThera Biosciences (Inst)
 
Pranav Rajpurkar
No Relationships to Disclose
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Celgene; Eisai; Ipsen; Novartis; Perthera; Valar Labs
Research Funding - Ipsen; NGM Biopharmaceuticals (Inst)
Travel, Accommodations, Expenses - Halozyme
Other Relationship - FibroGen
 
Eric Andrew Collisson
Stock and Other Ownership Interests - BloodQ; Clara Health; Guardant Health; HDT Bio; Hint Health; IHP Therapeutics; One Medical; Tatara Therapeutics; Valar Labs
Research Funding - AstraZeneca (Inst); Ferro Oncology/Bridge Bio (Inst); Loxo/Bayer (Inst); Merck KGaA (Inst)
Expert Testimony - NantBioScience
 
Anirudh Joshi
Employment - Valar Labs
Stock and Other Ownership Interests - Valar Labs
Patents, Royalties, Other Intellectual Property - Neuromodulation Tool
 
Aatur D. Singhi
Honoraria - Foundation Medicine